Search clinical trials for: BeneFIX Regulatory Post Marketing Commitment Plan

Total 71871 results

Geisinger Clinic

Completed

Evaluation of a Letter Intervention Promoting a Plant-based Diet

Cardiovascular Diseases | Obesity | Diabetes Mellitus

United States
Pfizer

Completed

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

Breast Neoplasms

United States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
University of Connecticut
Academy of Nutrition and Dietetics; Hartford HealthCare; Seafood Industry Research... and other collaborators

Active, not recruiting

Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer

Depression | Pain | Breast Cancer | Fatigue | Stress | Sleep Disturbance | Dietary Habits | Survivorship

United States
Bristol-Myers Squibb

Completed

A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China

Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck

China
Bayer

Completed

Stivarga Regulatory Post-Marketing Surveillance Study in Korea (StivargaPMS)

Colorectal Neoplasms

Korea, Republic of
Novo Nordisk A/S

Enrolling by invitation

Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2

Korea, Republic of
Network for Engineering and Economics Research...

Completed

Impact Evaluation of Triggerise's Tiko Platform

Contraception | Iron Deficiency Anemia of Pregnancy | Antenatal Care | Postnatal Care

India
Jazz Pharmaceuticals

Completed

An Observational Post-Marketing Safety Registry of Sativex®

Multiple Sclerosis | Diabetes | Cancer | Neuropathic Pain
Sanofi Pasteur, a Sanofi Company

Completed

Regulatory Post-Marketing Surveillance Study for TETRAXIM™

Pertussis | Tetanus | Diphtheria | Poliomyelitis

Korea, Republic of
Boehringer Ingelheim

Completed

Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Korea, Republic of
Bristol-Myers Squibb

Completed

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Venous Thromboembolism

Japan
Novo Nordisk A/S

Completed

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Pfizer

Completed

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Hong Kong, United States, Spain, Israel, Finland, Thailand, Turkey, Taiwan, Poland, Czechia, Malaysia, South Africa, Mexico, China, Australia, Slovakia, United Kingdom, New Zealand, Jordan, Canada, Netherlands, Brazil, Colombia, Puerto... and more
Novo Nordisk A/S

Completed

A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

Obesity | Overweight

Korea, Republic of
XenoPort, Inc.

Completed

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study (CONCORD)

Restless Legs Syndrome

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Schizophrenia | Bipolar Disorder
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (PERSIST)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis | Rheumatoid Diseases

Spain, Canada, Greece, United Kingdom, Germany, Bulgaria, Czechia
Mid Atlantic Retina

Completed

Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

Retinal Detachment | Macular Hole

United States
Bayer

Completed

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Contraception

Korea, Republic of
Boehringer Ingelheim

Completed

A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

Hypertension

Korea, Republic of
Bayer

Completed

Regulatory Post Marketing Surveillance Study in Korea

Endometriosis

Korea, Republic of
Bristol-Myers Squibb

Completed

Eliquis Regulatory Post Marketing Surveillance

NonValvular Atrial Fibrillation

Korea, Republic of
Hospital de Clinicas de Porto Alegre

Unknown

Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty

Cicatrix | Surgical Procedure, Unspecified | Rhinoplasty | Surgery, Plastic | Healing Scar

Brazil
AbbVie

Completed

Surveillance of Humira in Korean JIA Patients

Polyarticular Juvenile Idiopathic Arthritis
Melva Louisa

Completed

Isomil Post Marketing Observational Study

Cow's Milk Allergy

Indonesia
Merck KGaA, Darmstadt, Germany
Merck Ltd., India

Terminated

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (PMS LAD SCCHN)

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHN

India
GlaxoSmithKline

Completed

Regulatory Nebilet PMS (Nebilet PMS)

Heart Failure | Hypertension

Korea, Republic of
St. Jude Children's Research Hospital

Terminated

Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma

Neuroblastoma

United States
Bayer
Janssen Research & Development, LLC

Completed

Xarelto Regulatory Post-Marketing Surveillance

Venous Thromboembolism

Korea, Republic of
Yung Shin Pharm. Ind. Co., Ltd.
National Cheng-Kung University Hospital; Tri-Service General Hospital; Taichung...

Completed

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Squamous Cell Carcinoma of the Head and Neck | Nonsmall Cell Lung Cancer
Genzyme, a Sanofi Company

Completed

Vandetanib Risk Minimisation Effectiveness

Medullary Thyroid Cancer

Canada
Sanofi Pasteur, a Sanofi Company

Completed

Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)

Hepatitis A

Korea, Republic of
Bristol-Myers Squibb

Completed

Eliquis Regulatory Post Marketing Surveillance (rPMS)

Venous Thromboembolism

Korea, Republic of
Peking University Third Hospital
Peking University; Shanghai Greenvalley Pharmaceutical Co., Ltd.

Completed

Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

Adverse Drug Reaction

China
Bayer

Completed

Regulatory Post Marketing Surveillance Study on Nexavar®

Carcinoma, Renal Cell | Carcinoma, Hepatocellular

Korea, Republic of
Merit Medical Systems, Inc.

Completed

Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter (MCENPS)

Pain; Dialysis Catheter

United States
China Academy of Chinese Medical Sciences
Guangdong Provincial Hospital of Traditional Chinese Medicine; Guang'anmen... and other collaborators

Unknown

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

China
King Faisal Specialist Hospital & Research Center
Saudi National Comprehensive Plan for Science & Technology

Completed

Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality

Generic Drug Quality | Generic Formulation Interchangeability

Saudi Arabia
GlaxoSmithKline

Completed

Regulatory Hycamtin(Oral) PMS (Hycamtin PMS)

Lung Cancer, Small Cell

Korea, Republic of
Bayer

Completed

Regulatory Post Marketing Surveillance Study on YAZ

Contraception | Acne | Premenstrual Syndrome

Korea, Republic of
GlaxoSmithKline

Completed

Regulatory TYKERB® Tablets PMS

Cancer

Korea, Republic of
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Hypertension
Pfizer

Completed

Post Marketing Observational Study of Reformulated BeneFIX

Hemophilia B

France
Merck KGaA, Darmstadt, Germany

Completed

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Head and Neck Cancer

Korea, Republic of
Bayer

Completed

Betaferon® Regulatory Post-Marketing Surveillance

Multiple Sclerosis | Clinically Isolated System

Korea, Republic of
Bayer

Completed

Kogenate FS Regulatory Post-Marketing Surveillance (KG0910KR)

Hemophilia A

Korea, Republic of
MedImmune LLC
RTI International

Completed

A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children

Asthma | Immunosuppression | Wheezing

United States
Merck KGaA, Darmstadt, Germany
Choice Pharma Taiwan

Completed

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

Carcinoma, Squamous Cell of Head and Neck

Taiwan
GlaxoSmithKline

Completed

Regulatory AVAMYS Nasal Spray PMS

Rhinitis, Allergic, Perennial and Seasonal

Korea, Republic of
Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of

Search clinical trials for: BeneFIX Regulatory Post Marketing Commitment Plan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations